Giant Biogene Holding Co (HKSE:02367) EV-to-EBITDA : 24.41 (As of May. 11, 2024)

Giant Biogene Holding Co EV-to-EBITDA Chart

Competitive Comparison of Giant Biogene Holding Co's EV-to-EBITDA

For the Household & Personal Products subindustry, Giant Biogene Holding Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giant Biogene Holding Co's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's EV-to-EBITDA falls into.

Giant Biogene Holding Co EV-to-EBITDA Calculation

Giant Biogene Holding Co's EV-to-EBITDA for today is calculated as:

Giant Biogene Holding Co's current Enterprise Value is HK$47,500 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,946 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Giant Biogene Holding Co  (HKSE:02367) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Giant Biogene Holding Co's PE Ratio for today is calculated as:

Giant Biogene Holding Co's share price for today is HK$52.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.619.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Giant Biogene Holding Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description